 |
New data provides clinical trial sponsors with the information they need to confidently embrace innovative solutions in response to COVID-19. The survey reveals shifts in attitudes and behaviors since the onset of COVID-19 – insight that clinical trial sponsors can leverage for enrollment and engagement success. Patients identify the solutions that matter most to them when deciding on clinical trial participation. Download volume 1 survey findings and see where medication delivery, reimbursement, travel assistance, study apps, study websites, and other solutions rank in importance. Get exclusive data that reveals the growing demand for telehealth and its long-term adoption. Also see how increased news coverage of COVID-19 has impacted clinical trial interest and willingness to participate. BBK Worldwide recognizes the challenges that the evolving clinical research landscape poses to clinical trial sponsors and is available to help identify and quickly implement solutions to minimize disruption to study timelines. About BBK Worldwide BBK Worldwide is committed to enhancing the clinical trial patient experience through a combination of services and technology-driven solutions that educate consumers, engage participants, unburden sites, and support sponsors. |
